Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH
Status:
Recruiting
Trial end date:
2022-02-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and
pharmacodynamics of single and multiple doses of ARO-HSD in healthy adult volunteers and in
patients with NASH or suspected NASH.